AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) was the target of a large drop in short interest in December. As of December 15th, there was short interest totaling 347,179 shares, a drop of 53.2% from the November 30th total of 741,815 shares. Currently, 1.4% of the company’s stock are short sold. Based on an average daily volume of 1,132,471 shares, the days-to-cover ratio is presently 0.3 days. Based on an average daily volume of 1,132,471 shares, the days-to-cover ratio is presently 0.3 days. Currently, 1.4% of the company’s stock are short sold.
AGF U.S. Market Neutral Anti-Beta Fund Stock Up 1.1%
Shares of NYSEARCA BTAL traded up $0.16 during midday trading on Monday, hitting $14.62. The stock had a trading volume of 1,348,006 shares, compared to its average volume of 758,083. The business’s 50 day moving average is $14.92 and its 200-day moving average is $16.01. AGF U.S. Market Neutral Anti-Beta Fund has a 52 week low of $14.08 and a 52 week high of $22.10. The company has a market cap of $365.38 million, a P/E ratio of 17.67 and a beta of -0.66.
Institutional Trading of AGF U.S. Market Neutral Anti-Beta Fund
A number of institutional investors and hedge funds have recently modified their holdings of BTAL. PMV Capital Advisers LLC lifted its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 13.1% in the second quarter. PMV Capital Advisers LLC now owns 151,160 shares of the company’s stock valued at $2,676,000 after acquiring an additional 17,455 shares during the period. Magnolia Private Wealth LLC increased its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 266.0% during the 2nd quarter. Magnolia Private Wealth LLC now owns 68,189 shares of the company’s stock valued at $1,207,000 after purchasing an additional 49,560 shares during the last quarter. J.Safra Asset Management Corp purchased a new stake in shares of AGF U.S. Market Neutral Anti-Beta Fund during the 2nd quarter valued at about $48,000. L.M. Kohn & Company bought a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund in the 2nd quarter worth approximately $570,000. Finally, Ethos Financial Group LLC boosted its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 24.7% in the second quarter. Ethos Financial Group LLC now owns 25,229 shares of the company’s stock worth $446,000 after buying an additional 5,004 shares during the last quarter.
About AGF U.S. Market Neutral Anti-Beta Fund
The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.
Featured Articles
- Five stocks we like better than AGF U.S. Market Neutral Anti-Beta Fund
- Do not delete, read immediately
- How the Rich Retire
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- How Long Will $1M Last in Retirement?
- [No Brainer Gold Play]: “Show me a better investment.”
Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.
